PortfoliosLab logoPortfoliosLab logo
APYX vs. GHC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

APYX vs. GHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Apyx Medical Corporation (APYX) and Graham Holdings Company (GHC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, APYX achieves a 16.57% return, which is significantly higher than GHC's 4.89% return.


APYX

1D
1.75%
1M
-1.21%
YTD
16.57%
6M
13.33%
1Y
104.00%
3Y*
-17.63%
5Y*
-17.35%
10Y*

GHC

1D
0.70%
1M
3.97%
YTD
4.89%
6M
3.78%
1Y
19.38%
3Y*
27.56%
5Y*
13.67%
10Y*
10.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

APYX vs. GHC - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
APYX
Apyx Medical Corporation
16.57%121.52%-39.69%11.97%-81.75%78.06%-14.89%6.28%
GHC
Graham Holdings Company
4.89%26.98%26.32%16.56%-3.02%19.25%-15.32%0.57%

Correlation

The correlation between APYX and GHC is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2019

0.21

Fundamentals

EPS

APYX:

-$0.30

GHC:

$90.63

PS Ratio

APYX:

2.26

GHC:

1.01

Total Revenue (TTM)

APYX:

$55.83M

GHC:

$3.75B

Gross Profit (TTM)

APYX:

$21.29M

GHC:

$1.10B

EBITDA (TTM)

APYX:

-$3.18M

GHC:

$722.08M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

APYX vs. GHC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APYX
APYX Risk / Return Rank: 7979
Overall Rank
APYX Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
APYX Sortino Ratio Rank: 7878
Sortino Ratio Rank
APYX Omega Ratio Rank: 7575
Omega Ratio Rank
APYX Calmar Ratio Rank: 8383
Calmar Ratio Rank
APYX Martin Ratio Rank: 8282
Martin Ratio Rank

GHC
GHC Risk / Return Rank: 6262
Overall Rank
GHC Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
GHC Sortino Ratio Rank: 5959
Sortino Ratio Rank
GHC Omega Ratio Rank: 5959
Omega Ratio Rank
GHC Calmar Ratio Rank: 6363
Calmar Ratio Rank
GHC Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

APYX vs. GHC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and Graham Holdings Company (GHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


APYXGHCDifference
Sharpe ratioReturn per unit of total volatility

+0.46

Sortino ratioReturn per unit of downside risk

+0.98

Omega ratioGain probability vs. loss probability

1.25

1.15

+0.10

Calmar ratioReturn relative to maximum drawdown

2.86

0.98

+1.87

Martin ratioReturn relative to average drawdown

6.86

2.58

+4.28

APYX vs. GHC - Sharpe Ratio Comparison

The current APYX Sharpe Ratio is 1.19, which is higher than the GHC Sharpe Ratio of 0.73. The chart below compares the historical Sharpe Ratios of APYX and GHC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

APYX vs. GHC - Drawdown Comparison

The maximum APYX drawdown since its inception was -94.99%, which is greater than GHC's maximum drawdown of -67.54%. Use the drawdown chart below to compare losses from any high point for APYX and GHC.


Loading charts...

Drawdown Indicators


APYXGHCDifference

Max Drawdown

Largest peak-to-trough decline

-94.99%

-67.54%

-27.45%

Max Drawdown (1Y)

Largest decline over 1 year

-36.59%

-19.78%

-16.81%

Max Drawdown (3Y)

Largest decline over 3 years

-88.52%

-19.78%

-68.74%

Max Drawdown (5Y)

Largest decline over 5 years

-94.99%

-20.52%

-74.47%

Max Drawdown (10Y)

Largest decline over 10 years

-62.55%

Current Drawdown

Current decline from peak

-76.55%

-3.47%

-73.08%

Average Drawdown

Average peak-to-trough decline

-57.06%

-19.29%

-37.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.21%

7.54%

+7.67%

Volatility

APYX vs. GHC - Volatility Comparison

Apyx Medical Corporation (APYX) has a higher volatility of 22.15% compared to Graham Holdings Company (GHC) at 6.51%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than GHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


APYXGHCDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.15%

6.51%

+15.64%

Volatility (6M)

Calculated over the trailing 6-month period

55.41%

16.58%

+38.83%

Volatility (1Y)

Calculated over the trailing 1-year period

87.90%

26.83%

+61.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

100.40%

26.11%

+74.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.04%

28.29%

+64.75%

Dividends

APYX vs. GHC - Dividend Comparison

APYX has not paid dividends to shareholders, while GHC's dividend yield for the trailing twelve months is around 0.64%.


PositionTTM20252024202320222021202020192018201720162015
APYX
Apyx Medical Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GHC
Graham Holdings Company
0.64%0.66%0.79%0.95%1.05%0.96%1.09%0.87%0.83%0.91%0.95%89.61%

Financials

APYX vs. GHC - Financials Comparison

This section allows you to compare key financial metrics between Apyx Medical Corporation and Graham Holdings Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B20222023202420252026
12.42M
0
(APYX) Total Revenue
(GHC) Total Revenue
Values in USD except per share items

Frequently Asked Questions


APYX and GHC have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

APYX has higher volatility (22.15%) compared to GHC (6.51%). In terms of maximum drawdown, APYX dropped -94.99% vs GHC's -67.54%.

APYX currently has the higher Sharpe Ratio (1.19 vs 0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for APYX and GHC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer